Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 923289-30-9 | MDL No. : | MFCD11113360 |
Formula : | C9H10BrNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | IWIPLJLNRFDOQO-UHFFFAOYSA-N |
M.W : | 244.09 | Pubchem ID : | 42602738 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 55.23 |
TPSA : | 52.32 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.27 cm/s |
Log Po/w (iLOGP) : | 1.78 |
Log Po/w (XLOGP3) : | 2.14 |
Log Po/w (WLOGP) : | 2.25 |
Log Po/w (MLOGP) : | 1.54 |
Log Po/w (SILICOS-IT) : | 2.13 |
Consensus Log Po/w : | 1.97 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.91 |
Solubility : | 0.3 mg/ml ; 0.00123 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.87 |
Solubility : | 0.329 mg/ml ; 0.00135 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.36 |
Solubility : | 0.107 mg/ml ; 0.000437 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.62 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | Stage #1: With aluminum (III) chloride In chlorobenzene at 20 - 30℃; for 0.166667 h; Stage #2: With boron trichloride In chlorobenzene at 0 - 100℃; Stage #3: With water In isopropyl alcohol; toluene at 50℃; |
Step 3; Bromoanisidine.HCl (5.73g, 24.0 mmol), Aluminumtrichloride (3.52g) and chlorobenzene (15.0 mL) are charged into an oven dried 100 mL three necked flask at rt (temperature rise to 300C). The resulting mixture is then stirred for 10 min then cooled to 0-50C followed by slow addition of acetonitrile (1.89 mL, 36.0 mmol) followed by addition of BCl3 (2.82g), transferred as gas (or liquid) into the reaction mixture, keeping the temperature below 5 0C. The resulting mixture is then stirred at rt for 20 min then heated to 85-1000C for 16h. HPLC indicate completion of the reaction (SM<0.5percent at 220nm). The mixture is cooled down to 500C then Toluene (15mL) was added followed by slow addition of IPA (11.ImL) then slow addition of water (32mL) at 500C. The resulting mixture stirred for additional 2h at this temperature then 3g Celite was added and the stirred mixture cooled to rt. Filtration then wash of the organic fraction with water lxl5mL, 2xl5m: 5percentNaHCO3, lxl5mL water then concentration under reduced pressure provided 3.92-4.4g of the desired product in 68- 72percent isolated yield. 1H NMR (400 MHz, CDCl3)δ: 7.72 (d, / = 9.0 Hz, IH), 7.1 (br s, 2H), 6.28 (d, / = 9.1 Hz, IH), 3.94 (s, 3H), 2.55 (s, 3H). |
[ 864293-44-7 ]
2-Amino-5-bromo-3-methoxybenzoic acid
Similarity: 0.76
[ 169045-04-9 ]
2-Amino-5-bromo-4-methoxybenzoic acid
Similarity: 0.76
[ 111049-68-4 ]
Methyl 4-amino-5-bromo-2-methoxybenzoate
Similarity: 0.75
[ 328400-86-8 ]
2-Bromo-4-methoxy-5-methylaniline
Similarity: 0.75
[ 42465-54-3 ]
1-(2-Amino-3-methoxyphenyl)ethanone
Similarity: 0.74
[ 864293-44-7 ]
2-Amino-5-bromo-3-methoxybenzoic acid
Similarity: 0.76
[ 169045-04-9 ]
2-Amino-5-bromo-4-methoxybenzoic acid
Similarity: 0.76
[ 111049-68-4 ]
Methyl 4-amino-5-bromo-2-methoxybenzoate
Similarity: 0.75
[ 328400-86-8 ]
2-Bromo-4-methoxy-5-methylaniline
Similarity: 0.75
[ 169044-96-6 ]
Methyl 2-amino-5-bromo-4-methoxybenzoate
Similarity: 0.74
[ 864293-44-7 ]
2-Amino-5-bromo-3-methoxybenzoic acid
Similarity: 0.76
[ 169045-04-9 ]
2-Amino-5-bromo-4-methoxybenzoic acid
Similarity: 0.76
[ 111049-68-4 ]
Methyl 4-amino-5-bromo-2-methoxybenzoate
Similarity: 0.75
[ 328400-86-8 ]
2-Bromo-4-methoxy-5-methylaniline
Similarity: 0.75
[ 42465-54-3 ]
1-(2-Amino-3-methoxyphenyl)ethanone
Similarity: 0.74
[ 42465-54-3 ]
1-(2-Amino-3-methoxyphenyl)ethanone
Similarity: 0.74
[ 912347-94-5 ]
1-(2-Amino-4-methoxy-3-methylphenyl)ethanone
Similarity: 0.73
[ 56759-32-1 ]
1-(4-Amino-3-bromophenyl)ethanone
Similarity: 0.72
[ 60080-98-0 ]
(2-Bromo-5-methoxyphenyl)(phenyl)methanone
Similarity: 0.72
[ 892152-26-0 ]
7-Bromo-6-methoxy-2,3-dihydro-1H-inden-1-one
Similarity: 0.71
[ 864293-44-7 ]
2-Amino-5-bromo-3-methoxybenzoic acid
Similarity: 0.76
[ 169045-04-9 ]
2-Amino-5-bromo-4-methoxybenzoic acid
Similarity: 0.76
[ 111049-68-4 ]
Methyl 4-amino-5-bromo-2-methoxybenzoate
Similarity: 0.75
[ 328400-86-8 ]
2-Bromo-4-methoxy-5-methylaniline
Similarity: 0.75
[ 42465-54-3 ]
1-(2-Amino-3-methoxyphenyl)ethanone
Similarity: 0.74